Our Services
Medical Information
Helpful Resources
Published on: 9/13/2026
Low albumin (hypoalbuminemia) can point to either advanced liver disease, where the liver cannot produce enough albumin, or kidney disease such as nephrotic syndrome, where albumin is lost in the urine, but it is also common in malnutrition, inflammation, infection, and gut disorders that impair absorption. Because the causes overlap, doctors interpret albumin alongside liver enzymes, bilirubin, urine protein, and kidney function tests rather than in isolation. Symptoms like swelling in the legs, abdominal fluid buildup, foamy urine, jaundice, or unexplained fatigue help narrow down whether the liver, kidneys, or another condition is responsible. There are several important factors and warning signs to consider, so see below to understand more before assuming a diagnosis.
Since a single lab value rarely tells the whole story, mapping your symptoms is the fastest way to know which direction to look and how urgently to act. Take a free, instant, online symptom check to see which conditions match your pattern and what next steps make sense for you.
Last reviewed for medical accuracy: 09/12/2026
Albumin is the most abundant protein in human blood plasma, produced by the liver. It helps:
Normal serum albumin ranges from about 3.5 to 5.0 g/dL. Levels below 3.5 g/dL are considered low (hypoalbuminemia). Because albumin reflects both liver function and overall nutritional and metabolic health, low albumin can signal various underlying issues—most notably liver failure or kidney disease.
The liver is solely responsible for making albumin. In chronic or acute liver injury, albumin production drops. Key points include:
A drop in albumin alone doesn’t confirm liver failure. Clinicians look at the full picture—symptoms like jaundice, bleeding tendencies, and imaging studies such as ultrasound or CT.
Healthy kidneys retain albumin, preventing its loss into urine. In kidney disease, glomerular filtration barrier damage lets albumin leak out:
In kidney disease, low albumin combines with edema (fluid retention) and elevated cholesterol. A kidney specialist (nephrologist) uses tests like renal ultrasound, biopsy, and blood work to pinpoint the cause.
While liver and kidney diseases are major contributors, hypoalbuminemia can stem from:
Low albumin by itself may not cause symptoms until levels are very low. Look for:
Addressing the underlying cause is key. For example, treating liver disease may involve antiviral therapy for hepatitis, abstaining from alcohol, or liver transplantation. Kidney disease treatment can include blood pressure control (ACE inhibitors), immunosuppression for glomerulonephritis, and dietary protein management.
A systematic approach helps differentiate liver from kidney causes:
Based on results, healthcare providers tailor treatment to the identified cause, monitoring albumin trends over time.
Managing low albumin revolves around the root problem:
Regular follow-up with blood and urine tests helps ensure albumin levels improve as treatment progresses.
If you notice persistent swelling, unexplained weight gain or loss, yellowing of the skin or eyes, or sudden changes in urination, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. It can help you decide how urgently to seek care.
However, nothing replaces professional evaluation. If you experience any of the following, speak to a doctor immediately:
Always discuss lab results and treatment options with your physician. If you suspect a serious issue or have life-threatening symptoms, seek medical attention right away.
(References)
* Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004 Nov-Dec;17(6):432-7. doi: 10.1111/j.0894-0959.2004.17603.x. PMID: 15660573.
* Siddall EC, Radhakrishnan J. The pathophysiology of edema formation in the nephrotic syndrome. Kidney Int. 2012 Sep;82(6):635-42. doi: 10.1038/ki.2012.180. Epub 2012 Jun 20. PMID: 22718186.
* Bang JY, Kim SO, Kim SG, Song JG, Kang J, Kim JW, Ha S. Impact of the serum albumin level on acute kidney injury after cerebral artery aneurysm clipping. PLoS One. 2018;13(11):e0206731. doi: 10.1371/journal.pone.0206731. Epub 2018 Nov 5. PMID: 30395651; PMCID: PMC6218058.
* Holle J, Gratopp A, Balmer S, Varnholt V, Henning S, Bufler P, Müller D, Rosenfeld L. Single-Pass Albumin Dialysis in the Treatment of Children with Liver Failure. Blood Purif. 2020;49(1-2):55-62. doi: 10.1159/000502938. Epub 2019 Sep 17. PMID: 31527371.
* Fagenson AM, Gleeson EM, Pitt HA, Lau KN. Albumin-Bilirubin Score vs Model for End-Stage Liver Disease in Predicting Post-Hepatectomy Outcomes. J Am Coll Surg. 2020 Apr;230(4):637-645. doi: 10.1016/j.jamcollsurg.2019.12.007. Epub 2020 Jan 16. PMID: 31954813.
* Amouzandeh M, Sundström A, Wahlin S, Wernerman J, Rooyackers O, Norberg Å. Albumin and fibrinogen synthesis rates in advanced chronic liver disease. Am J Physiol Gastrointest Liver Physiol. 2023 Nov 1;325(5):G391-G397. doi: 10.1152/ajpgi.00072.2023. Epub 2023 Aug 22. PMID: 37605837.
* Uasuwannakul A, Lertudomphonwanit C, Anantasit N, Tanpowpong P, Getsuwan S, Thirapattaraphan C, Treepongkaruna S. Postoperative hypoalbuminemia and outcomes of pediatric liver transplantation. BMC Pediatr. 2024 Jun 12;24(1):392. doi: 10.1186/s12887-024-04831-x. Epub 2024 Jun 12. PMID: 38867183; PMCID: PMC11167898.
* Wang X, Wen P, Gao F, Zhao J, Miao S. Microbiota-friendly diet ameliorates hypoalbuminemia in chronic kidney disease: evidence from NHANES. Front Immunol. 2025;16:1546031. doi: 10.3389/fimmu.2025.1546031. Epub 2025 May 6. PMID: 40396178; PMCID: PMC12088941.
* Oishi H, Koutake Y, Ebata N, Nagasaki Y, Hashimoto M. Teicoplanin total trough concentration and adverse effects in patients with hypoalbuminemia. J Infect Chemother. 2025 Oct;31(10):102807. doi: 10.1016/j.jiac.2025.102807. Epub 2025 Sep 4. PMID: 40914495.
* Li Q, Tong H, Liu X, Liao F, Ma H, Zhou Z, Liu F, Shi H, Wang Z, Sun Y, Yao Q, Feng Y, Li X, Feng J, He Z, Peng Y, Bai Z, Zhu R, Cheng D, Xu C, He S, Yu H, Xie C, Yuan J, Wang X, Yang H, Zou Y, Li S, Li T, Hu S, Chen C, Chen Z, Lantinga MA, Bernardi M, Qi X, Tang C, On the behalf of Young Member Group of Chinese Gastroenterology Society. Human Albumin infusion in liver Cirrhosis and overt Hepatic Encephalopathy (HACHE): protocol of an investigator-initiated, open-label, multicentre, randomised controlled trial. BMJ Open. 2025 Nov 5;15(11):e094300. doi: 10.1136/bmjopen-2024-094300. Epub 2025 Nov 5. PMID: 41198206; PMCID: PMC12593439.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.